Kubota Pharmaceutical Holdings Management
Management criteria checks 2/4
Kubota Pharmaceutical Holdings' CEO is Ryo Kubota, appointed in Jan 2002, has a tenure of 21.17 years. directly owns 18.66% of the company’s shares, worth $8.59M. The average tenure of the management team and the board of directors is 7.8 years and 2.2 years respectively.
Key information
Ryo Kubota
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 21.2yrs |
CEO ownership | 18.7% |
Management average tenure | 7.8yrs |
Board average tenure | 2.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2022 | n/a | n/a | -JP¥2b |
Sep 30 2022 | n/a | n/a | -JP¥2b |
Jun 30 2022 | n/a | n/a | -JP¥2b |
Mar 31 2022 | n/a | n/a | -JP¥3b |
Dec 31 2021 | n/a | n/a | -JP¥3b |
Sep 30 2021 | n/a | n/a | -JP¥2b |
Jun 30 2021 | n/a | n/a | -JP¥3b |
Mar 31 2021 | n/a | n/a | -JP¥2b |
Dec 31 2020 | n/a | n/a | -JP¥2b |
Sep 30 2020 | n/a | n/a | -JP¥3b |
Jun 30 2020 | n/a | n/a | -JP¥3b |
Mar 31 2020 | n/a | n/a | -JP¥3b |
Dec 31 2019 | n/a | n/a | -JP¥3b |
Sep 30 2019 | n/a | n/a | -JP¥3b |
Jun 30 2019 | n/a | n/a | -JP¥3b |
Mar 31 2019 | n/a | n/a | -JP¥3b |
Dec 31 2018 | JP¥85m | JP¥62m | -JP¥3b |
Sep 30 2018 | n/a | n/a | -JP¥3b |
Jun 30 2018 | n/a | n/a | -JP¥3b |
Mar 31 2018 | n/a | n/a | -JP¥3b |
Dec 31 2017 | n/a | n/a | -JP¥3b |
Sep 30 2017 | n/a | n/a | -JP¥4b |
Jun 30 2017 | n/a | n/a | -JP¥3b |
Mar 31 2017 | n/a | n/a | -JP¥3b |
Dec 31 2016 | JP¥564m | JP¥62m | -JP¥4b |
Compensation vs Market: Insufficient data to establish whether Ryo's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Ryo's compensation has been consistent with company performance over the past year.
CEO
Ryo Kubota (56 yo)
21.2yrs
Tenure
JP¥84,604,000
Compensation
Dr. Ryo Kubota, M.D., Ph D., Founded Acucela Inc. in 2002 and has been its Chairman since April 2005, Chief Executive Officer and President since December 2015. Dr. Kubota Founded Kubota Pharmaceutical Hol...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 21.2yrs | JP¥84.60m | 18.66% ¥ 8.6m | |
Director of Investor Relations & Communication | no data | no data | no data | |
Chief Business Officer of Acucela Inc | 7.8yrs | JP¥59.49m | no data | |
Executive Vice President of Research & Development - Acucela Inc | 7.6yrs | JP¥178.53m | no data |
7.8yrs
Average Tenure
56yo
Average Age
Experienced Management: KBBT.F's management team is seasoned and experienced (7.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 20.8yrs | JP¥84.60m | 18.66% ¥ 8.6m | |
Lead Independent Director | 7yrs | JP¥60.14m | 0.0015% ¥ 672.2 | |
Director | 2.2yrs | no data | 0.00018% ¥ 82.9 | |
Director | 1.2yrs | no data | no data | |
Director | 1.2yrs | no data | no data |
2.2yrs
Average Tenure
Experienced Board: KBBT.F's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.